A THC-like substance that occurs naturally in humans and other vertebrates helps maintain immunity, memory, nerve function and more – and research suggests a lack of it can harm health.
Academic rigor, journalistic flair
Articles on Cannabinoids
Displaying 1 - 20 of 23 articles
Studies suggest that marijuana and CBD use might help relieve chronic pain while also reducing a patient’s need for opioids.
With the dual threats of antibiotic resistance and emerging pandemics, finding new drugs becomes even more urgent. A trove of medicines may be lying under our nose.
Different painkillers provide relief in different ways. The most effective medication is the one that best targets the type of pain you’re experiencing with minimal side effects.
A growing body of research points to the body’s natural cannabinoid system as the primary driver behind the runner’s high – and the mental health boost and stress relief following exercise.
Cannabis labelling is often misleading. Labelling cannabis products with quantities of key compounds will help consumers make informed decisions.
Weed, though far less dangerous than many other drugs, is not entirely without risk. Some 59% of people treating pain with medical cannabis experience moderate to severe withdrawal symptoms
The jury’s still out on whether or not CBD relieves stress and anxiety.
Cannabis use is common among trauma survivors, and may improve some of the symptoms of those with PTSD.
There is no doubt a regulated market for access to medicinal cannabis is safer, but if cannabis-based products were allowed to bypass efficacy trials, there’s a potential cost to patient safety.
Radula liverwort shares an intriguing similarity to cannabis – researchers are working out what it does to the brain.
We’ve got better at managing the health risks of traditional drugs of abuse, but novel psychoactive substances, or ‘legal highs’, are a dangerous unknown.
As Canada moves towards legalization of cannabis in 2018, there is growing evidence of the drug’s potential to treat opioid addiction itself, as well as the chronic pain that often drives it.
Mexico and Canada are about to turn medical cannabis into North America’s most lucrative new market.
NSW is about to embark on the largest and most definitive clinical trial ever of medicinal cannabis for chemotherapy-induced nausea and vomiting.
The Australian government will now accept licence applications for groups wanting to grow cannabis for scientific and medical purposes. But there’s still a lot we don’t know about this complex plant.
With restrictions to cannabis loosening at the state level, research is badly needed to get the facts in order.
New psychoactive substances, same problematic users.
147m people used the drug last year. We need to know much more about it.
Synthetic cannabinoids – drugs that mimic the psychoactive effect of cannabis – have been linked to injuries and deaths. And when one is banned, another rises to take its place.
Top contributors
-
Research Scientist, BC Centre on Substance Use and Assistant Professor in the Division of AIDS, Department of Medicine, University of British Columbia
-
Professor of Psychopharmacology and NHMRC Principal Research Fellow, University of Sydney
-
PhD student in Population and Public Health, University of British Columbia
-
Assistant Professor of Psychiatry and Behavioral Neurosciences, Wayne State University
-
Senior Lecturer in Human Rights, Constitutional Law and Legal Theory, University of Wollongong
-
Senior Research Fellow, St George's, University of London
-
Associate Professor in Psychopharmacology and Addiction Medicine at the School of Psychology, University of Sydney
-
Director, Southern Cross Plant Science, Southern Cross University
-
Postdoctoral Research Associate in Cancer Research, Newcastle University
-
Reader in Crimimology and Social Policy, University of Birmingham
-
Reader & Director of MANDRAKE, Manchester Metropolitan University
-
Assistant Professor of Psychology, West Virginia University
-
Research Associate, University of Connecticut
-
Medical oncologist from Chris O`Brien Lifehouse cancer hospital, Lead researcher NSW Government clinical trial into the role of cannabis-derived medicines in chemotherapy-induced nausea and vomiting, Clinical Associate Professor., University of Sydney
-
Assistant Professor, University of California, San Francisco
